Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Droia Oncology Ventures

Droia Oncology Ventures
VC INVESTOR TYPE
Active STATUS
6 PROFESSIONALS
14 INVESTMENTS
9 PORTFOLIO
3 EXITS
Description

Droia Oncology Ventures is a venture capital firm that focuses on the development of oncology therapies and early-stage drug development companies. The firm was founded in 2011 and participates in the development of the portfolio companies aiming to support them at least up to clinical proof of concept.

Website
Investor Status
Actively Seeking New Investments
Year Founded
2011
Primary Investor Type
Venture Capital
Primary Office
  • Brusselsesteenweg 11
  • 1860 Meise
  • Belgium

+32 02 000 00 00

Droia Oncology Ventures Investments (14)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cyteir Therapeutics 15-Oct-2019 Later Stage VC 000.00 Biotechnology Startup 0000 000 0000000
00000000 000000000 25-Jun-2019 00000 00000 0000 Drug Discovery Pre-Clinical Trials 000000000 0000000
0000 00000000000 13-Dec-2018 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1
0000 000000 25-May-2018 00000 00000 0000 Biotechnology Startup
0000000 0000000000 28-Feb-2018 00000 00000 000.00 Drug Discovery Generating Revenue 000000000 0000000
00000 00000000000 03-Nov-2017 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable
0000000 0000000000 19-Jan-2017 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 000000000 0000000
0000000 18-Jan-2017 00000 00000 000.00 Drug Discovery Generating Revenue 000000000 0000000
Pact Pharma 20-Dec-2016 Early Stage VC 000.00 Biotechnology Startup
Bioncotech 06-Oct-2016 Later Stage VC Drug Discovery Clinical Trials - Phase 2
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Droia Oncology Ventures’s full profile, request a free trial.

Droia Oncology Ventures Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
Tusk Therapeutics 01-Oct-2018 Merger/Acquisition 00000 Completed
00000 00000000000 15-Mar-2018 000 00000 Completed
00 000000000000 01-Aug-2016 000 00 00000000 Completed
To view this investor’s complete exits history, request access »

Droia Oncology Ventures Team (7)

Name Title Deals Funds Boards Office Contact
Info
Bart Van Hooland Co-Founding Partner 0 0 Meise, Belgium
Joke Vereecken Principal Meise, Belgium
Matthias Van Woensel Ph.D Principal Meise, Belgium
Sandra Schoors Ph.D Principal Meise, Belgium
Luc Verelst Co-Founder & Chairman 0 0 Meise, Belgium
You’re viewing 5 of 7 team members. Get the full list »

Droia Oncology Ventures Co-Investors (55)

Name With Exits Lead Partner
Advent Life Sciences 2 0
Celgene 0 0 0
GV 0 0 0
Taiho Ventures 0 0
The Invus Group 0 0
To view this investor’s complete co-investor history, request access »